DrugDoctor: enhancing drug recommendation in cold-start scenario via visit-level representation learning and training.

Medication recommendation is a crucial application of artificial intelligence in healthcare. Current methodologies mostly depend on patient-level longitudinal representation, which utilizes the entirety of historical electronic health records for making predictions. However, they tend to overlook a few key elements: (1) The need to analyze the impact of past medications on previous conditions. (2) Similarity in patient visits is more common than similarity in the complete medical histories of patients. (3) It is difficult to accurately represent patient-level longitudinal data due to the varying numbers of visits. To our knowledge, current models face difficulties in dealing with initial patient visits (i.e. in cold-start scenarios) which are common in clinical practice. This paper introduces DrugDoctor, an innovative drug recommendation model crafted to emulate the decision-making mechanics of human doctors. Unlike previous methods, DrugDoctor explores the visit-level relationship between prescriptions and diseases while considering the impact of past prescriptions on the patient's condition to provide more accurate recommendations. We design a plug-and-play block to effectively capture drug substructure-aware disease information and effectiveness-aware medication information, employing cross-attention and multi-head self-attention mechanisms. Furthermore, DrugDoctor adopts a fundamentally new visit-level training strategy, aligning more closely with the practices of doctors. Extensive experiments conducted on the MIMIC-III and MIMIC-IV datasets demonstrate that DrugDoctor outperforms 10 other state-of-the-art methods in terms of Jaccard, F1-score, and PRAUC. Moreover, DrugDoctor exhibits strong robustness in handling patients with varying numbers of visits and effectively tackles "cold-start" issues in medication combination recommendations. [ABSTRACT FROM AUTHOR]